CNS Pharmaceuticals CNSP Q2 2024 earnings
Reported August 14, 2024 · Before market open
EPS estimate-$3,585.43
Next report
Aug 17, 2026 (in a month)EPS estimate-$0.24
Versus estimates
Diluted EPS
Q1 2026-$7.30Miss by $1.93Q4 2025-$5.09In lineQ3 2025-$5.76Beat by $0.87Q2 2025-$6.42Beat by $3.18Q3 2024-$150.06Miss by $149.96
Q2 2024-$4,033.61Miss by $448.18
Ask the moment CNS Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did CNS Pharmaceuticals report Q2 2024 earnings?
- CNS Pharmaceuticals (CNSP) reported Q2 2024 earnings on August 14, 2024 before market open.
- What were CNS Pharmaceuticals's Q2 2024 revenue and EPS?
- CNS Pharmaceuticals reported diluted EPS of $-4033.61 for Q2 2024.
- Did CNS Pharmaceuticals beat estimates in Q2 2024?
- EPS missed the consensus estimate of $-3585.43 by $448.18.
- Where can I find CNS Pharmaceuticals's Q2 2024 SEC filings?
- You can read the 10-Q periodic report (0001683168-24-005711) directly on SEC EDGAR. The filing index links above go to sec.gov.